Literature DB >> 3792917

Mycobacterial aetiology of Crohn's disease: serologic study using common mycobacterial antigens and a species-specific glycolipid antigen from Mycobacterium paratuberculosis.

S N Cho, P J Brennan, H H Yoshimura, B I Korelitz, D Y Graham.   

Abstract

Crohn's disease is a granulomatous form of enteritis superficially similar to Johne's disease (paratuberculosis) of ruminants. Recently, a Mycobacterium sp closely related to Mycobacterium paratuberculosis was cultured from tissues of patients with Crohn's disease suggesting that M paratuberculosis may be the aetiologic agent in some cases. In addition, greater seroreactivity to M paratuberculosis has been reported in patients with Crohn's disease. In the present study, we have evaluated the serum antibody response to disrupted M paratuberculosis using ELISA and serum specimens from 33 people with Crohn's disease, 21 with ulcerative colitis, and 12 non-inflammatory bowel disease controls. We failed to find a consistent IgG, IgM, or IgA antibody response to Mycobacterium paratuberculosis. The results indicate that, as in bovine paratuberculosis, serum seroreactivity is not a reliable tool for examining the relationship between human intestinal disease and mycobacteria.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3792917      PMCID: PMC1434076          DOI: 10.1136/gut.27.11.1353

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  10 in total

1.  The 7H11 medium for the cultivation of mycobacteria.

Authors:  M L Cohn; R F Waggoner; J K McClatchy
Journal:  Am Rev Respir Dis       Date:  1968-08

2.  Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae.

Authors:  S W Hunter; T Fujiwara; P J Brennan
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

3.  The effect of different antibody affinities on ELISA absorbance and titer.

Authors:  O P Lehtonen; E Eerola
Journal:  J Immunol Methods       Date:  1982-10-29       Impact factor: 2.303

4.  Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.

Authors:  M J Blaser; R A Miller; J Lacher; J W Singleton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

5.  Possible role of mycobacteria in inflammatory bowel disease. II. Mycobacterial antibodies in Crohn's disease.

Authors:  W R Thayer; J A Coutu; R J Chiodini; H J Van Kruiningen; R S Merkal
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

6.  A glycolipid antigen specific to Mycobacterium paratuberculosis: structure and antigenicity.

Authors:  R T Camphausen; R L Jones; P J Brennan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.

Authors:  S N Cho; D L Yanagihara; S W Hunter; R H Gelber; P J Brennan
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Enzyme-linked immunosorbent assay (ELISA): a study of antibodies to Mycobacterium tuberculosis in the IgG, IgA and IgM classes in tuberculosis, sarcoidosis and Crohn's disease.

Authors:  J M Grange; J Gibson; E Nassau; T Kardjito
Journal:  Tubercle       Date:  1980-09

9.  Possible role of mycobacteria in inflammatory bowel disease. I. An unclassified Mycobacterium species isolated from patients with Crohn's disease.

Authors:  R J Chiodini; H J Van Kruiningen; W R Thayer; R S Merkal; J A Coutu
Journal:  Dig Dis Sci       Date:  1984-12       Impact factor: 3.199

10.  Cross-reactivity of antigens from the cytoplasm and cell walls of some corynebacteria and mycobacteria.

Authors:  C Abou-Zeid; M Harboe; B Sundsten; C Cocito
Journal:  J Infect Dis       Date:  1985-01       Impact factor: 5.226

  10 in total
  16 in total

1.  Immunoglobulin A (IgA) and IgG serum antibodies to mycobacterial antigens in Crohn's disease patients and their relatives.

Authors:  L G Wayne; D Hollander; B Anderson; H A Sramek; C M Vadheim; J I Rotter
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

2.  Mycobacterium paratuberculosis DNA in Crohn's disease tissue.

Authors:  J D Sanderson; M T Moss; M L Tizard; J Hermon-Taylor
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

3.  Effect of intestinal resection on serum antibodies to the mycobacterial 45/48 kilodalton doublet antigen in Crohn's disease.

Authors:  G Kreuzpaintner; P K Das; A Stronkhorst; A W Slob; G Strohmeyer
Journal:  Gut       Date:  1995-09       Impact factor: 23.059

Review 4.  Paratuberculosis.

Authors:  C Cocito; P Gilot; M Coene; M de Kesel; P Poupart; P Vannuffel
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

5.  Preliminary report on isolation of mycobacteria from patients with Crohn's disease.

Authors:  G Gitnick; J Collins; B Beaman; D Brooks; M Arthur; T Imaeda; M Palieschesky
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

6.  Investigations on etiology of Crohn's disease. Humoral immune response to stress (heat shock) proteins.

Authors:  D C Markesich; E T Sawai; J S Butel; D Y Graham
Journal:  Dig Dis Sci       Date:  1991-04       Impact factor: 3.199

7.  Clinical usefulness of serological measurements obtained by antigen 60 in mycobacterial infections: development of a new concept.

Authors:  R Maes
Journal:  Klin Wochenschr       Date:  1991-10-02

8.  Antibodies to Mycobacterium paratuberculosis and nine species of environmental mycobacteria in Crohn's disease and control subjects.

Authors:  K J Stainsby; J R Lowes; R N Allan; J P Ibbotson
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

9.  Nucleotide sequence analysis and seroreactivities of the 65K heat shock protein from Mycobacterium paratuberculosis.

Authors:  F A el-Zaatari; S A Naser; L Engstrand; P E Burch; C Y Hachem; D L Whipple; D Y Graham
Journal:  Clin Diagn Lab Immunol       Date:  1995-11

10.  Circulating antibodies to heat-shock protein 60 in Crohn's disease and ulcerative colitis.

Authors:  T R Stevens; V R Winrow; D R Blake; D S Rampton
Journal:  Clin Exp Immunol       Date:  1992-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.